Jpmorgan Chase & CO Sanara Med Tech Inc. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 13,574 shares of SMTI stock, worth $426,495. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,574
Previous 4,058
234.5%
Holding current value
$426,495
Previous $122,000
268.85%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding SMTI
# of Institutions
50Shares Held
942KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA201KShares$6.31 Million0.0% of portfolio
-
Black Rock Inc. New York, NY197KShares$6.19 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA87.9KShares$2.76 Million0.0% of portfolio
-
State Street Corp Boston, MA64.2KShares$2.02 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL40.8KShares$1.28 Million0.0% of portfolio
About Sanara MedTech Inc.
- Ticker SMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 8,303,730
- Market Cap $261M
- Description
- Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...